Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 151235, 8 pages
http://dx.doi.org/10.1155/2014/151235
Research Article

Efficacy and Safety of Clearing Heat and Detoxifying Injection in the Treatment of Influenza: A Randomized, Double-Blinded, Placebo-Controlled Trial

1The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, No. 816 Zhenli Road, Hebei District, Tianjin 300150, China
2The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, No. 314 Anshanxi Road, Naikai District, Tianjin 300193, China
3Jiangsu Hospital of Integrated Traditional Chinese and Western Medicine, No. 100 Shizi Street, Hongshan Road, Nanjing 210028, China
4The First Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine, No. 54 Youdian Road, Shangyou District, Hangzhou 310006, China
5Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, No. 10 Huadong Road, Nanning 530011, China

Received 22 June 2014; Revised 9 September 2014; Accepted 28 October 2014; Published 25 November 2014

Academic Editor: Hongcai Shang

Copyright © 2014 Yu Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. L. Nichol, A. Lind, K. L. Margolis et al., “The effectiveness of vaccination against influenza in healthy, working adults,” The New England Journal of Medicine, vol. 333, no. 14, pp. 889–893, 1995. View at Publisher · View at Google Scholar · View at Scopus
  2. S. A. Harper, J. S. Bradley, J. A. Englund et al., “Seasonal influenza in adults and children-diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the infectious diseases society of America,” Clinical Infectious Diseases, vol. 48, no. 8, pp. 1003–1032, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. W. W. Thompson, D. K. Shay, E. Weintraub et al., “Mortality associated with influenza and respiratory syncytial virus in the United States,” The Journal of the American Medical Association, vol. 289, no. 2, pp. 179–186, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. S. C. Schoenbaum, “Economic impact of influenza. The individual's perspective,” The American Journal of Medicine, vol. 82, no. 6, pp. 26–30, 1987. View at Google Scholar · View at Scopus
  5. A. S. Monto, “Individual and community impact of influenza,” PharmacoEconomics, vol. 16, no. 1, pp. 1–6, 1999. View at Google Scholar · View at Scopus
  6. K. M. Neuzil, B. G. Mellen, P. F. Wright, E. F. Mitchel Jr., and M. R. Griffin, “The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children,” The New England Journal of Medicine, vol. 342, no. 4, pp. 225–231, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Z. Wang, X. L. Cui, Y. J. Gao et al., “Anti-virus test of gardenia extract,” China Journal of Chinese Materia Medica, vol. 31, pp. 1176–1178, 2006. View at Google Scholar
  8. J. F. Zhang, H. Y. Zheng, and T. Jian, “Inhibition mechanism of artemisinin on herpes simplex virus,” Jiangsu Pharmaceutical and Clinical Research, vol. 13, pp. 11–14, 2005. View at Google Scholar
  9. Y. M. Li, L. Li, C. Bai, D. Li, and T. Z. Wang, “Effect of extract from honey suckle flower on anti- adenovirus,” West China Journal of pharmaceutical Sciences, vol. 16, pp. 327–329, 2001. View at Google Scholar
  10. Y. Z. Feng, F. Zhou, M. Huang, and W. Yao, “Inhibition effect of Reduning injection on influenza virus-FMI,” Chinese Journal of New Drugs and Clinical Remedies, vol. 26, pp. 663–667, 2007. View at Google Scholar
  11. Y. Z. Feng, F. Zhou, M. Huang, and K. Yao, “Vitro inhibition effect of Reduning injection on adenovirus-3,” Chinese Journal of New Drugs and Clinical Remedies, vol. 26, pp. 573–577, 2007. View at Google Scholar
  12. L. Sun, A. L. Liu, Z. Z. Wang, Y. A. Bi, G. H. Du, and W. Xiao, “Inhibition effect of Reduning injection and its components on influenza virus neuraminidase,” Modern Medicine and Clinical, vol. 29, pp. 27–31, 2014. View at Google Scholar
  13. X. M. Huang, Y. J. Liu, Y. Z. He, F. F. Chen, and Y. K. Wang, “Clinical observation of Reduning injection in treatment of patients with acute upper respiratory tract infections,” Chinese Journal of Clinical Pharmacology and Therapeutics, vol. 11, article 470, 2006. View at Google Scholar
  14. S. Y. Ying, “Clinical observation of Reduning injection in treatment of children acute upper respiratory tract infection with fever,” China Medical Herald, vol. 3, article 116, 2006. View at Google Scholar
  15. M. H. Ebell, M. Call, and J. Shinholser, “Effectiveness of oseltamivir in adults: a meta-analysis of published and unpublished clinical trials,” Family Practice, vol. 30, no. 2, pp. 125–133, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Aoki, A. Osterhaus, G. Rimmelzwaan, N. Kinnersley, and P. Ward, “Oral GS4104 succesfully reduces duration and severity of naturally acquired influenza,” in Proceedings of the 38th International Conference on Antimicrobial Agents and Chenmotherapy, Abstract LB-5, San Diego, Calif, USA, September 1998.
  17. Y. Q. Qian, “Verifing the efficacy of Reduning injection in the treatment 35 cases of acute respiratory infections,” Guide of China Medicine, vol. 11, p. 476, 2013. View at Google Scholar
  18. B. Y. Cui and K. W. Gao, “Reduning injection in the treatment of pediatric respiratory tract infection in 120 cases,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 5, pp. 31–32, 2013. View at Google Scholar
  19. W. Y. Tian, “Adverse reactions of 93 cases reduning injection,” Guiding Journal of Traditional Chinese Medicine and Pharmacy, vol. 18, pp. 84–86, 2012. View at Google Scholar
  20. J. J. Treanor, F. G. Hayden, P. S. Vrooman et al., “Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial,” The Journal of the American Medical Association, vol. 283, no. 8, pp. 1016–1024, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. A. M. Fry, D. Goswami, K. Nahar et al., “Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial,” The Lancet Infectious Diseases, vol. 14, no. 2, pp. 109–118, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. South East Asia Infectious Disease Clinical Research Network, “Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trial,” The British Medical Journal, vol. 346, Article ID f3039, 2013. View at Publisher · View at Google Scholar
  23. A. P. Smith, M. Thomas, P. Brockman, J. Kent, and K. G. Nicholson, “Effect of influenza B virus infection on human performance,” British Medical Journal, vol. 306, no. 6880, pp. 760–761, 1993. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Keech, A. J. Scott, and P. J. J. Ryan, “The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population,” Occupational Medicine, vol. 48, no. 2, pp. 85–90, 1998. View at Publisher · View at Google Scholar · View at Scopus
  25. Centers for Disease Control and Prevention, “Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP),” MMWR—Recommendations and Reports, vol. 47, pp. 1–21, 1998. View at Google Scholar
  26. F. G. Hayden, R. B. Belshe, R. D. Clover, A. J. Hay, M. G. Oakes, and W. Soo, “Emergence and apparent transmission of rimantadine-resistant influenza A virus in families,” The New England Journal of Medicine, vol. 321, no. 25, pp. 1696–1702, 1989. View at Publisher · View at Google Scholar · View at Scopus
  27. F. G. Hayden, J. M. Gwaltney Jr., R. L. van De Castle, K. F. Adams, and B. Giordani, “Comparative toxicity of amantadine hydrochloride and rimantadine hydrochloride in healthy adults,” Antimicrobial Agents and Chemotherapy, vol. 19, no. 2, pp. 226–233, 1981. View at Publisher · View at Google Scholar · View at Scopus
  28. F. G. Hayden, A. D. Osterhaus, J. J. Treanor et al., “Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections,” The New England Journal of Medicine, vol. 337, no. 13, pp. 874–880, 1997. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Campion, C. A. Silagy, O. Keene et al., “Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections,” The Lancet, vol. 352, no. 9144, pp. 1877–1881, 1998. View at Publisher · View at Google Scholar · View at Scopus
  30. A. S. Monto, D. M. Fleming, D. Henry et al., “Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza A and B virus infections,” The Journal of Infectious Diseases, vol. 180, no. 2, pp. 254–261, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. D. P. Calfee, A. W. Peng, and L. M. R. Cass, “Protective efficacy of intravenous zanamivir in experimental human influenza,” in Proceedings of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, Abstract A332, San Diego, Calif, USA, 1998.
  32. K. G. Nicholson, F. Y. Aoki, A. D. M. E. Osterhaus et al., “Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial,” The Lancet, vol. 355, no. 9218, pp. 1845–1850, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Strong, J. Burrows, E. Stedman, and P. Redgrave, “Adverse drug effects following oseltamivir mass treatment and prophylaxis in a school outbreak of 2009 pandemic influenza A(H1N1) in June 2009, Sheffield, United Kingdom,” Eurosurveillance, vol. 15, no. 19, article 5, 2010. View at Google Scholar · View at Scopus
  34. A. Wallensten, I. Oliver, D. Lewis, and S. Harrison, “Compliance and side effects of prophylactic oseltamivir treatment in a school in South West England,” Euro Surveillance, vol. 14, no. 30, article 19285, 2009. View at Google Scholar · View at Scopus
  35. H. M. Deng, “Efficacy of Reduning injection in the treatment of children with acute bronchopneumonia,” International Medicine & Health Guidance News, vol. 14, pp. 94–96, 2008. View at Google Scholar
  36. J. F. Xiang, J. Chen, Q. Dong, and Y. Z. Wang, “Reduning injection in the treatment of children with viral pneumonia in 46 cases,” Zhejiang Journal of Traditional Chinese Medicine, vol. 46, no. 9, p. 701, 2011. View at Publisher · View at Google Scholar